Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 29, 2024 | (Q4)Dec 29, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (FY)Jan 1, 2023 | (FY)Jan 2, 2022 | (Q3)Oct 2, 2016 | (Q2)Jul 3, 2016 | (Q1)Apr 3, 2016 | (FY)Jan 3, 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 33.14%916M | -1.59%683M | -8.87%688M | 694M | -30.99%521M | 755M | 1,033.57%317.4M | 225.70%209.1M | -6,993.33%-319.2M | 797.8M |
Net income from continuing operations | 700.00%798M | 265.65%217M | -134.19%-133M | ---131M | 108.48%811M | --389M | 72.63%143.8M | 32.25%137.8M | 24.74%121M | --452.3M |
Operating gains losses | 0.00%-28M | -166.67%-34M | 0.00%-28M | --51M | -1,553.57%-463M | ---28M | -7.04%-7.6M | -3,850.00%-7.9M | -45.00%-5.8M | ---199M |
Depreciation and amortization | -20.61%339M | -34.35%86M | 29.00%427M | --131M | 32.93%440M | --331M | 5.30%61.6M | 3.25%60.3M | 1.03%58.6M | --234.1M |
Deferred tax | 170.00%91M | ---- | -506.25%-130M | ---- | -93.75%2M | --32M | ---- | ---- | ---- | --63.9M |
Other non cash items | ---- | ---- | --1M | ---- | ---1M | ---- | ---- | ---- | ---- | ---- |
Change In working capital | -151.82%-285M | -58.24%322M | 1,733.33%550M | --771M | -1,126.67%-308M | --30M | 205.85%117.6M | 113.09%14.2M | -217.04%-493M | --243.2M |
-Change in receivables | -103.82%-6M | ---- | 7,950.00%157M | ---- | -1,550.00%-33M | ---2M | ---- | ---- | ---- | --83.5M |
-Change in inventory | -70.58%138M | ---- | 354.89%469M | ---- | -66.85%-307M | ---184M | ---- | ---- | ---- | --141.5M |
-Change in prepaid assets | -254.39%-88M | ---- | 338.46%57M | ---- | -276.92%-23M | --13M | ---- | ---- | ---- | --66.8M |
-Change in payables and accrued expense | -107.41%-280M | ---- | -152.33%-135M | ---- | -62.40%97M | --258M | ---- | ---- | ---- | --102.5M |
-Change in other working capital | -2,550.00%-49M | 150.22%558M | 103.64%2M | --223M | 23.64%-42M | ---55M | ---- | ---- | ---- | ---151.1M |
Cash from discontinued investing activities | -36.13%221M | 0 | 1,016.13%346M | 152M | -112.90%-4M | 31M | ||||
Operating cash flow | 9.96%1.14B | -19.27%683M | 31.55%1.03B | --846M | -34.22%517M | --786M | 1,033.57%317.4M | 225.70%209.1M | -6,993.33%-319.2M | --797.8M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -53.61%-298M | 105.22%7M | 4.90%-194M | -134M | 234.31%274M | -204M | -4.23%-123.1M | -138.83%-92.3M | -14.79%-91.6M | -75M |
Capital expenditure reported | 0.85%-350M | 26.13%-82M | -70.53%-353M | ---111M | -63.29%-338M | ---207M | -19.89%-113.9M | -7.22%-83.2M | -13.44%-76.8M | ---375.2M |
Net PPE purchase and sale | -54.79%99M | 2,933.33%91M | 3,550.00%219M | --3M | 33.33%8M | --6M | ---- | ---- | -72.73%300K | --6.4M |
Net business purchase and sale | 7.14%-13M | -60.00%-8M | -1,300.00%-14M | ---5M | 58,500.00%584M | ---1M | ---- | ---- | ---- | --354M |
Net investment purchase and sale | --0 | ---- | --0 | ---- | --21M | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | 26.09%-34M | 128.57%6M | -2,200.00%-46M | ---21M | 50.00%-1M | ---2M | 60.17%-9.2M | 76.60%-8.8M | -14.39%-15.1M | ---60.2M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -45.65%-469M | 104.29%7M | 2.42%-322M | ---163M | 158.48%193M | ---330M | -4.23%-123.1M | -138.83%-92.3M | -14.79%-91.6M | ---75M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 9.07%-321M | 62.65%-31M | 18.66%-353M | -83M | -30.65%-567M | -434M | -468.69%-36.5M | -47.59%-257.4M | 87.28%-35.4M | -446.5M |
Net issuance payments of debt | -190.91%-32M | -120.00%-11M | 95.22%-11M | ---5M | 93.04%-16M | ---230M | -66.67%3.3M | -9.08%55.1M | 119.77%38.2M | ---126.5M |
Cash dividends paid | 10.84%-288M | 70.49%-18M | -68.23%-323M | ---61M | -158.33%-496M | ---192M | ---39.8M | ---262.5M | ---73.6M | ---30M |
Net other financing activities | 94.74%-1M | 88.24%-2M | -58.33%-19M | ---17M | -358.33%-55M | ---12M | --0 | ---- | ---- | ---290M |
Cash from discontinued financing activities | 20.56%-143M | 0 | -285.57%-180M | 18M | -7.22%90M | 97M | ||||
Financing cash flow | 12.95%-464M | 52.31%-31M | -58.16%-533M | ---65M | -41.54%-477M | ---337M | -468.69%-36.5M | -47.59%-257.4M | 87.28%-35.4M | ---446.5M |
Net cash flow | ||||||||||
Beginning cash position | 31.75%751M | 120.63%278M | 174.04%570M | --126M | 56.25%325M | --208M | -38.82%119.3M | 289.54%260.6M | 62.61%704.9M | --433.5M |
Current changes in cash | 14.61%204M | 6.62%660M | 48.33%178M | --619M | 94.17%233M | --120M | 296.76%157.8M | -210.27%-140.6M | -23.09%-446.2M | --276.3M |
Effect of exchange rate changes | -500.00%-12M | -16.67%5M | 200.00%3M | --6M | 500.00%12M | ---3M | 25.00%500K | -216.67%-700K | 146.34%1.9M | ---4.9M |
End cash Position | 25.57%943M | 25.57%943M | 131.08%751M | --751M | 75.38%570M | --325M | 140.97%277.6M | -38.82%119.3M | 289.54%260.6M | --704.9M |
Free cash flow | 15.57%787M | -18.23%601M | 17.62%681M | --735M | -69.08%179M | --579M | 403.73%203.5M | 1,039.55%125.9M | -448.48%-396M | --422.6M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |